OptiChroniX

We (https://optichronix.com/team ) bring 100 years of combined experience, which gives us an edge to innovate at the intersection of biomedical, behavioural, computing and engineering in the highly regulated Medical Devices space and develop Rx (Class IIa SaMD) with a view to mitigating cognitive decline in patients affected by Alzheimer’s disease and associated co-morbidities.